PL377601A1 - Sposoby przewidywania zachowania samobójczego podczas leczenia - Google Patents

Sposoby przewidywania zachowania samobójczego podczas leczenia

Info

Publication number
PL377601A1
PL377601A1 PL377601A PL37760104A PL377601A1 PL 377601 A1 PL377601 A1 PL 377601A1 PL 377601 A PL377601 A PL 377601A PL 37760104 A PL37760104 A PL 37760104A PL 377601 A1 PL377601 A1 PL 377601A1
Authority
PL
Poland
Prior art keywords
prediction
methods
during treatment
suicidality during
suicidality
Prior art date
Application number
PL377601A
Other languages
English (en)
Inventor
Sridhar Kudaravalli
Elisabeth Marie Leroy
Mihael Hristos Polymeropoulos
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL377601A1 publication Critical patent/PL377601A1/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406Neurotransmitters
    • G01N33/9413Dopamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
PL377601A 2003-02-21 2004-02-20 Sposoby przewidywania zachowania samobójczego podczas leczenia PL377601A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44901803P 2003-02-21 2003-02-21

Publications (1)

Publication Number Publication Date
PL377601A1 true PL377601A1 (pl) 2006-02-06

Family

ID=32908683

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377601A PL377601A1 (pl) 2003-02-21 2004-02-20 Sposoby przewidywania zachowania samobójczego podczas leczenia

Country Status (9)

Country Link
US (1) US20070065821A1 (pl)
EP (1) EP1597392A1 (pl)
JP (1) JP2006518206A (pl)
CN (1) CN1754000A (pl)
AU (1) AU2004213582A1 (pl)
CA (1) CA2516484A1 (pl)
MX (1) MXPA05008793A (pl)
PL (1) PL377601A1 (pl)
WO (1) WO2004074513A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090281090A1 (en) * 2004-06-04 2009-11-12 Novartis Ag Biomarkers for the prediction of responsiveness to clozapine treatment
US8930178B2 (en) 2007-01-04 2015-01-06 Children's Hospital Medical Center Processing text with domain-specific spreading activation methods
EP2149047A4 (en) * 2007-04-30 2010-05-19 Univ Ohio State Res Found POLYMORPHISMS IN GENES WITH INFLUENCE ON DOPAMINTRANSPORTER DISEASES AND ITS APPLICATIONS
WO2008144371A1 (en) * 2007-05-16 2008-11-27 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for diagnosing suicidal tendencies
EP3522172B1 (en) 2009-04-27 2021-10-20 Children's Hospital Medical Center Method for assessing a neuropsychiatric condition of a human subject
WO2011119227A2 (en) * 2010-03-25 2011-09-29 Columbia Northwest Pharmaceuticals, Llc Compositions for the treatment of central nervous system disorders including depression employing novel drug combination therapy to reduce suicidality in patients
JP6061935B2 (ja) * 2011-09-14 2017-01-18 ザ ヘンリー エム. ジャクソン ファウンデーション フォー ザ アドバンスメント オブ ミリタリー メディシン,インコーポレーテッド 心的外傷後ストレス障害(ptsd)のための診断用バイオマーカーを検出及び監視するため、並びに同障害の自殺型と非自殺型とを識別するためのプロセス及びキット
FR2993889B1 (fr) 2012-07-27 2014-08-22 Michelin & Cie Composition de caoutchouc thermo-expansible pour pneumatique
US9938576B1 (en) 2012-09-21 2018-04-10 Ohio State Innovation Foundation Materials and methods for determining metabolizer status in humans
WO2014201515A1 (en) * 2013-06-18 2014-12-24 Deakin University Medical data processing for risk prediction
CA2918054C (en) 2013-07-11 2022-12-13 The Johns Hopkins University A dna methylation and genotype specific biomarker of suicide attempt and/or suicide ideation
FR3009306B1 (fr) 2013-07-30 2015-07-31 Michelin & Cie Pneu dont la zone sommet est pourvue d’une couche interne reduisant les bruits de roulage
FR3009305A1 (fr) 2013-07-30 2015-02-06 Michelin & Cie Composition de caoutchouc thermo-expansible et pneumatique comportant une telle composition

Also Published As

Publication number Publication date
WO2004074513A1 (en) 2004-09-02
JP2006518206A (ja) 2006-08-10
MXPA05008793A (es) 2006-02-22
CA2516484A1 (en) 2004-09-02
CN1754000A (zh) 2006-03-29
EP1597392A1 (en) 2005-11-23
US20070065821A1 (en) 2007-03-22
AU2004213582A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
ZA200508427B (en) Methods for treating interleuking-6 related diseases
IL174014A0 (en) Methods for the treatment of endometriosis
EP1613308A4 (en) CANCER TREATMENT METHODS
ZA200504558B (en) Compounds for the treatment of metabolic disorders
EG24420A (en) Treatment of ophthalmic conditions
AU2003286567A8 (en) Methods for the treatment of skin disorders
EP1635813A4 (en) COMBINATION THERAPY FOR THE TREATMENT OF DYSLIPIDEMIA
EP1635763A4 (en) METHOD FOR TREATING NEURODEEGENERATIVE ILLNESSES
EP1643986A4 (en) PHENYLCARBOXYLATE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
GB0329874D0 (en) Compounds useful for the treatment of diseases
GB0320238D0 (en) Treatment of disease
PL377601A1 (pl) Sposoby przewidywania zachowania samobójczego podczas leczenia
EP1651237A4 (en) METHOD FOR THE TREATMENT OF DERMATOLOGICAL ILLNESSES
EP1667827A4 (en) PROCESS FOR TREATING WOOD
GB0306309D0 (en) Method of treatment
GB0302572D0 (en) Method of treatment
GB0221712D0 (en) Methods of treatment
EP1648469A4 (en) ANTIGLUCOCORTICOIDES FOR THE TREATMENT OF CATATONIA
GB0327975D0 (en) Methods of treatment
GB0307544D0 (en) Treatment method
GB0302691D0 (en) Treatment method
GB0702858D0 (en) Dressinf for tissue treatment
GB0322921D0 (en) Methods of treatment
GB0325259D0 (en) Therapeutic agents for the treatment of bone conditions
GB0310463D0 (en) Therapeutic agents for the treatment of bone conditions

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)